Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Prognostic significance of serum S100B protein in high-risk surgically resected melanoma patients participating in Intergroup Trial ECOG 1694.

Tarhini AA, Stuckert J, Lee S, Sander C, Kirkwood JM.

J Clin Oncol. 2009 Jan 1;27(1):38-44. doi: 10.1200/JCO.2008.17.1777. Epub 2008 Dec 1. Erratum in: J Clin Oncol. 2012 Nov 1;30(31):3903.

2.

[Role of S100B protein in neoplasms and other diseases].

Bánfalvi T, Gergye M, Beczássy E, Gilde K, Ottó S.

Magy Onkol. 2004;48(1):71-4. Epub 2004 Apr 23. Review. Hungarian.

3.

S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma.

Harpio R, Einarsson R.

Clin Biochem. 2004 Jul;37(7):512-8. Review.

PMID:
15234232
4.

The evolution of S100B inhibitors for the treatment of malignant melanoma.

Hartman KG, McKnight LE, Liriano MA, Weber DJ.

Future Med Chem. 2013 Jan;5(1):97-109. doi: 10.4155/fmc.12.191. Review.

5.

Circulating serologic and molecular biomarkers in malignant melanoma.

Palmer SR, Erickson LA, Ichetovkin I, Knauer DJ, Markovic SN.

Mayo Clin Proc. 2011 Oct;86(10):981-90. doi: 10.4065/mcp.2011.0287. Review.

Supplemental Content

Support Center